Developing Clinical Trials for Oncology Part 3: Growth Trends in Oncology Therapeutics

Posted: 09/21/2011

More than ever clinical trials are more complicated and more difficult to run. Denis Mir, Senior Manager of Clinical Operations in Oncology at Eisai Global Clinical Development, shares his thoughts on the key drivers and innovations supporting growth in oncology therapeutics and the challenges around the corner. For the full interview go to Developing Clinical Trials for Oncology - Denis Mir, Eisai Global Clinical Development

To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

Have Your Say
Rate this feature and give us your feedback in the comments section below